These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 20409444

  • 1. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs GS, Goodwin FK, Baldessarini RJ.
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [Abstract] [Full Text] [Related]

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Apr; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 3. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
    Altshuler L, Suppes T, Black D, Nolen WA, Keck PE, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R.
    Am J Psychiatry; 2003 Jul; 160(7):1252-62. PubMed ID: 12832239
    [Abstract] [Full Text] [Related]

  • 4. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
    Goldberg JF, Brooks JO, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME.
    J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946
    [Abstract] [Full Text] [Related]

  • 5. Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial.
    El-Mallakh RS, Vöhringer PA, Ostacher MM, Baldassano CF, Holtzman NS, Whitham EA, Thommi SB, Goodwin FK, Ghaemi SN.
    J Affect Disord; 2015 Sep 15; 184():318-21. PubMed ID: 26142612
    [Abstract] [Full Text] [Related]

  • 6. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS.
    Am J Psychiatry; 2006 Feb 15; 163(2):210-6. PubMed ID: 16449473
    [Abstract] [Full Text] [Related]

  • 7. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.
    Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, Mintz J.
    J Clin Psychiatry; 2001 Aug 15; 62(8):612-6. PubMed ID: 11561933
    [Abstract] [Full Text] [Related]

  • 8. Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data.
    Mizushima J, Uchida H, Tada M, Suzuki T, Mimura M, Nio S.
    J Clin Psychiatry; 2017 Feb 15; 78(2):e146-e151. PubMed ID: 28234437
    [Abstract] [Full Text] [Related]

  • 9. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM.
    Am J Psychiatry; 2006 Feb 15; 163(2):232-9. PubMed ID: 16449476
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
    Goldberg JF, Perlis RH, Ghaemi SN, Calabrese JR, Bowden CL, Wisniewski S, Miklowitz DJ, Sachs GS, Thase ME.
    Am J Psychiatry; 2007 Sep 15; 164(9):1348-55. PubMed ID: 17728419
    [Abstract] [Full Text] [Related]

  • 11. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.
    J Affect Disord; 2015 Oct 01; 185():31-7. PubMed ID: 26143402
    [Abstract] [Full Text] [Related]

  • 12. Does recent mania affect response to antidepressants in bipolar disorder? A re-analysis of STEP-BD data.
    Mousavi Z, Johnson S, Li D.
    J Affect Disord; 2018 Aug 15; 236():136-139. PubMed ID: 29734096
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of depressive and bipolar disorder patients with mixed features.
    Tondo L, Vázquez GH, Pinna M, Vaccotto PA, Baldessarini RJ.
    Acta Psychiatr Scand; 2018 Sep 15; 138(3):243-252. PubMed ID: 29862493
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of antidepressant's use in the treatment of depressive episodes in bipolar disorder - review of research.
    Antosik-Wójcińska AZ, Stefanowski B, Święcicki Ł.
    Psychiatr Pol; 2015 Sep 15; 49(6):1223-39. PubMed ID: 26909398
    [Abstract] [Full Text] [Related]

  • 15. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD, Wang CH, Shwarz M, Shults J.
    J Affect Disord; 2009 Jan 15; 112(1-3):219-30. PubMed ID: 18486235
    [Abstract] [Full Text] [Related]

  • 16. The long-term course of rapid-cycling bipolar disorder.
    Coryell W, Solomon D, Turvey C, Keller M, Leon AC, Endicott J, Schettler P, Judd L, Mueller T.
    Arch Gen Psychiatry; 2003 Sep 15; 60(9):914-20. PubMed ID: 12963673
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant-induced mania in bipolar patients: identification of risk factors.
    Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M.
    J Clin Psychiatry; 2001 Apr 15; 62(4):249-55. PubMed ID: 11379838
    [Abstract] [Full Text] [Related]

  • 18. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul 15; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 19. Antidepressants in bipolar disorder: the case for caution.
    Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK.
    Bipolar Disord; 2003 Dec 15; 5(6):421-33. PubMed ID: 14636365
    [Abstract] [Full Text] [Related]

  • 20. Illness risk following rapid versus gradual discontinuation of antidepressants.
    Baldessarini RJ, Tondo L, Ghiani C, Lepri B.
    Am J Psychiatry; 2010 Aug 15; 167(8):934-41. PubMed ID: 20478876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.